Literature DB >> 15793674

[Recommendations of the German Society of Rheumatology on therapy of pulmonary hypertension in patients with autoimmune diseases].

H Schulze-Koops1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15793674     DOI： 10.1007/s00393-005-0693-9

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  9 in total

1.  Sildenafil in primary pulmonary hypertension.

Authors:  S Prasad; J Wilkinson; M A Gatzoulis
Journal:  N Engl J Med       Date:  2000-11-02       Impact factor: 91.245

Review 2.  Chronic thromboembolic pulmonary hypertension.

Authors:  P F Fedullo; W R Auger; K M Kerr; L J Rubin
Journal:  N Engl J Med       Date:  2001-11-15       Impact factor: 91.245

Review 3.  Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension.

Authors:  Nazzareno Galiè; Werner Seeger; Robert Naeije; Gerald Simonneau; Lewis J Rubin
Journal:  J Am Coll Cardiol       Date:  2004-06-16       Impact factor: 24.094

4.  Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension.

Authors:  D Abrams; I Schulze-Neick; A G Magee
Journal:  Heart       Date:  2000-08       Impact factor: 5.994

5.  Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension.

Authors:  H Wilkens; A Guth; J König; N Forestier; B Cremers; B Hennen; M Böhm; G W Sybrecht
Journal:  Circulation       Date:  2001-09-11       Impact factor: 29.690

6.  Sildenafil for primary and secondary pulmonary hypertension.

Authors:  Hiroshi Watanabe; Kyoichi Ohashi; Kazuhiko Takeuchi; Kazuhiro Yamashita; Taku Yokoyama; Quang-Kim Tran; Hiroshi Satoh; Hajime Terada; Hiroyuki Ohashi; Hideharu Hayashi
Journal:  Clin Pharmacol Ther       Date:  2002-05       Impact factor: 6.875

7.  Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.

Authors:  Hossein Ardeschir Ghofrani; Ralph Wiedemann; Frank Rose; Horst Olschewski; Ralph Theo Schermuly; Norbert Weissmann; Werner Seeger; Friedrich Grimminger
Journal:  Ann Intern Med       Date:  2002-04-02       Impact factor: 25.391

8.  Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide.

Authors:  Evangelos Michelakis; Wayne Tymchak; Dale Lien; Linda Webster; Kyoko Hashimoto; Stephen Archer
Journal:  Circulation       Date:  2002-05-21       Impact factor: 29.690

9.  Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study.

Authors:  B K S Sastry; C Narasimhan; N Krishna Reddy; B Soma Raju
Journal:  J Am Coll Cardiol       Date:  2004-04-07       Impact factor: 24.094
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.